A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer
Journal of the American Chemical Society · 2026
DOI: 10.1021/jacs.6c00003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Sean T Gilpatrick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506, United States. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Mitochondria, Organogold Compounds, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506, United States.
- Department of Medicine, Division of Digestive Diseases and Nutrition, University of Kentucky College of Medicine, Lexington, Kentucky 40506, United States.
- Lexington Veterans Affairs Medical Center Kentucky, Lexington, Kentucky 40506, United States.
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky 40536, United States.
- Center for Pharmaceutical Research and Innovation, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536, United States.
- Markey NCI Comprehensive Cancer Center, University of Kentucky, Lexington, Kentucky 40536, United States.
ORCID-Profile: Christine F Brainson, Samuel G Awuah
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- CSRD VA
- NIDDK NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Department of Veterans Affairs
Zitieren
APA
Gilpatrick, S. T., Kim, J. H., Bhogoju, S., Kapur, N., Munugoda, U., Daraezinwa, J., Parkin, S., Barrett, T. A., Brainson, C. F., Plaugher, D. R., & Awuah, S. G. (2026). A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c00003
Vancouver
Gilpatrick ST, Kim JH, Bhogoju S, Kapur N, Munugoda U, Daraezinwa J, et al. A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c00003
BibTeX
@article{Gilpatrick2026,
author = {Gilpatrick, Sean T and Kim, Jong Hyun and Bhogoju, Sarayu and Kapur, Neeraj and Munugoda, Udara and Daraezinwa, Jovita and Parkin, Sean and Barrett, Terrence A and Brainson, Christine F and Plaugher, Daniel R and Awuah, Samuel G},
title = {A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c00003}
}
EUVIMED